Safety efforts in pediatric drug development (Record no. 152123)

MARC details
000 -LEADER
fixed length control field 01703nam a2200421Ia 4500
001 - CONTROL NUMBER
control field EBC3018953
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240121041623.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cn|||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 090731s2010 nyua sb 001 0 eng d
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
Canceled/invalid LC control number 2009031817
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9781612093680
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9781607415657 (hardcover)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 1607415658 (hardcover)
035 ## - SYSTEM CONTROL NUMBER
System control number (MiAaPQ)EBC3018953
035 ## - SYSTEM CONTROL NUMBER
System control number (Au-PeEL)EBL3018953
035 ## - SYSTEM CONTROL NUMBER
System control number (CaPaEBR)ebr10662759
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)699510130
040 ## - CATALOGING SOURCE
Original cataloging agency MiAaPQ
Transcribing agency MiAaPQ
Modifying agency MiAaPQ
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RJ560
Item number .S24 2010
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615/.190083
Edition number 22
245 00 - TITLE STATEMENT
Title Safety efforts in pediatric drug development
Medium [electronic resource] /
Statement of responsibility, etc. Conor D. Byrne, editor.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. New York :
Name of publisher, distributor, etc. Nova Science Publishers,
Date of publication, distribution, etc. c2010.
300 ## - PHYSICAL DESCRIPTION
Extent xiv, 133 p. :
Other physical details ill.
490 1# - SERIES STATEMENT
Series statement Pharmacology--research, safety testing and regulation series
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographical references and index.
533 ## - REPRODUCTION NOTE
Type of reproduction Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
610 10 - SUBJECT ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element United States.
Title of a work Best Pharmaceuticals for Children Act.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pediatric pharmacology
Geographic subdivision United States.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pediatrics
Geographic subdivision United States
General subdivision Formulae, receipts, prescriptions
-- Safety measures.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug development
Geographic subdivision United States
General subdivision Safety measures.
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Byrne, Conor D.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element ProQuest (Firm)
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Pharmacology-research, safety testing, and regulation series.
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=3018953">https://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=3018953</a>
Public note Click to View

No items available.